Xlife Sciences Past Earnings Performance
Past criteria checks 1/6
Xlife Sciences has been growing earnings at an average annual rate of 30.3%, while the Life Sciences industry saw earnings growing at 19.5% annually. Revenues have been growing at an average rate of 30.8% per year. Xlife Sciences's return on equity is 3.2%, and it has net margins of 1607.5%.
Key information
30.3%
Earnings growth rate
22.8%
EPS growth rate
Life Sciences Industry Growth | 17.6% |
Revenue growth rate | 30.8% |
Return on equity | 3.2% |
Net Margin | 1,607.5% |
Next Earnings Update | 23 Apr 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Xlife Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 23 | 1 | 16 | 6 | 0 |
31 Mar 23 | 1 | 15 | 6 | 0 |
31 Dec 22 | 1 | 14 | 5 | 0 |
30 Sep 22 | 1 | 32 | 5 | 0 |
30 Jun 22 | 1 | 49 | 5 | 0 |
31 Mar 22 | 1 | 51 | 6 | 0 |
31 Dec 21 | 1 | 53 | 6 | 0 |
30 Sep 21 | 1 | 34 | 5 | 0 |
30 Jun 21 | 1 | 14 | 5 | 0 |
31 Mar 21 | 0 | 18 | 4 | 0 |
31 Dec 20 | 0 | 21 | 3 | 0 |
30 Sep 20 | 0 | 14 | 2 | 0 |
30 Jun 20 | 1 | 6 | 2 | 0 |
31 Mar 20 | 1 | 3 | 1 | 0 |
31 Dec 19 | 1 | 1 | 1 | 0 |
Quality Earnings: XLS has a large one-off gain of CHF36.6M impacting its last 12 months of financial results to 30th June, 2023.
Growing Profit Margin: XLS's current net profit margins are lower than last year .
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: XLS's earnings have grown significantly by 30.3% per year over the past 5 years.
Accelerating Growth: XLS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: XLS had negative earnings growth (-67%) over the past year, making it difficult to compare to the Life Sciences industry average (-9.5%).
Return on Equity
High ROE: XLS's Return on Equity (3.2%) is considered low.